Autor(es):Mostrar menos -

da Silva, Patricia Bento ^{[1, 2]} ; Sousa Araujo, Victor Hugo ^[1] ; Fonseca-Santos, Bruno ^[1] ; Solcia, Mariana Cristina ^[1] ; Ribeiro, Camila Maringolo ^[1] ; da Silva, Isabel Cristiane ^[1] ; Alves, Renata Carolina ^[1] ; Pironi, Andressa Maria ^[1] ; Lopes Silva, Ana Carolina ^[1] ; Victorelli, Francesca Damiani ^[1] ; Fernandes, Mariza Aires ^[1] ; Ferreira, Paula Scanavez ^[1] ; da Silva, Gilmar Hanck ^[1] ; Pavan, Fernando Rogerio ^[1] ; Chorilli, Marlus ^[1]

Afiliação do(s) autor(es)

^[1] Sao Paulo State Univ UNESP, Sch Pharmaceut Sci, Araraquara, SP - Brazil

^[2] Univ Brasilia UnB, Inst Biol, Brasilia, DF - Brazil

• Tipo de documento: Artigo de Revisão
• Fonte: Current Medicinal Chemistry; v. 28, n. 10, p. 1906-1956, 2021.
• Citações Web of Science: 1

Resumo

The indiscriminate use of antibiotics has facilitated the growing resistance of bacteria, and this has become a serious public health problem worldwide. Several microorganisms are still resistant to multiple antibiotics and are particularly dangerous in the hospital and nursing home environment, and to patients whose care requires devices, such as ventilators and intravenous catheters. A list of twelve pathogenic genera, which especially included bacteria that were not affected by different antibiotics, was released by the World Health Organization (WHO) in 2017, and the research and development of new antibiotics against these genera has been considered a priority. The nanotechnology is a tool that offers an effective platform for altering the physical-chemical properties of different materials, thereby enabling the development of several biomedical applications. Owing to their large surface area and high reactivity, metallic particles on the nanometric scale have remarkable physical, chemical, and biological properties. Nanoparticles with sizes between 1 and 100 nm have several applications, mainly as new antimicrobial agents for the control of microorganisms. In the present review, more than 200 reports of various metallic nanoparticles, especially those containing copper, gold, platinum, silver, titanium, and zinc were analyzed with regard to their anti-bacterial activity. However, of these 200 studies, only 42 reported about trials conducted against the resistant bacteria considered a priority by the WHO. All studies are in the initial stage, and none are in the clinical phase of research. (AU)

• Processo FAPESP: 18/00163-0 - Desenvolvimento e busca de novos antimicrobianos contra Tuberculose: da triagem a estudos pré-clínicos in vivo
• Beneficiário: Fernando Rogério Pavan
• Modalidade de apoio: Auxílio à Pesquisa - Regular
• Processo FAPESP: 17/10016-2 - Sistemas precursores de cristais líquidos como estratégia para administração vaginal do peptídeo CTT1: desenvolvimento farmacotécnico e potencial aplicação no tratamento do câncer cervical
• Beneficiário: Marlus Chorilli
• Modalidade de apoio: Auxílio à Pesquisa - Regular
• Processo FAPESP: 13/14957-5 - Investigação do potencial contra tuberculose de uma nova classe de compostos furoxânicos e compostos nanoestruturados de rutênio(II) e cobre(II)
• Beneficiário: Fernando Rogério Pavan
• Modalidade de apoio: Auxílio à Pesquisa - Jovens Pesquisadores